UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3151
RCI Hospitality Holdings
RICK
$199M
| $15.1K | ﹤0.01% |
551
| – | – |
2025 Q4
2 quarters
|
|
3152
Caleres
CAL
$417M
| $15K | ﹤0.01% |
1,215
| – | – |
2021 Q1
21 quarters
|
|
3153
Global E Online
GLBE
$6.78B
| $14.8K | ﹤0.01% |
426
-271,522
| -100% | -$8.59M |
2025 Q4
2 quarters
|
|
3154
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.21B
| $14.8K | ﹤0.01% |
291
| – | – |
2026 Q1
1 quarter
|
|
3155
Keros Therapeutics
KROS
$237M
| $14.6K | ﹤0.01% |
1,366
| – | – |
2025 Q4
2 quarters
|
|
3156
Citizens & Northern Corp
CZNC
$447M
| $14.6K | ﹤0.01% |
625
| – | – |
2025 Q4
2 quarters
|
|
3157
Superior Group of Companies
SGC
$208M
| $14.5K | ﹤0.01% |
1,106
| – | – |
2025 Q4
2 quarters
|
|
|
RSVR
3158
Reservoir Media
RSVR
$633M
| $14.5K | ﹤0.01% |
1,466
| – | – |
2025 Q4
2 quarters
|
|
3159
Oportun Financial
OPRT
$410M
| $14.5K | ﹤0.01% |
2,532
| – | – |
2025 Q4
2 quarters
|
|
3160
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.04B
| $14.4K | ﹤0.01% |
94
-210
| -69% | -$29.2K |
2025 Q4
2 quarters
|
|
3161
AngioDynamics
ANGO
$484M
| $14.3K | ﹤0.01% |
1,102
| – | – |
2025 Q4
2 quarters
|
|
3162
Tecnoglass Holdings
TGLS
$1.67B
| $14.3K | ﹤0.01% |
306
| – | – |
2025 Q4
2 quarters
|
|
3163
Innovator US Equity 10 Buffer ETF Quarterly
ZALT
$802M
| $14.3K | ﹤0.01% |
422
| – | – |
2026 Q1
1 quarter
|
|
3164
CryoPort
CYRX
$879M
| $14.3K | ﹤0.01% |
908
| – | – |
2026 Q1
1 quarter
|
|
3165
Foghorn Therapeutics
FHTX
$119M
| $14K | ﹤0.01% |
2,876
| – | – |
2025 Q4
2 quarters
|
|
3166
Adams Diversified Equity Fund
ADX
$3.27B
| $13.9K | ﹤0.01% |
544
| – | – |
2026 Q1
1 quarter
|
|
3167
Puma Biotechnology
PBYI
$531M
| $13.9K | ﹤0.01% |
1,710
| – | – |
2026 Q1
1 quarter
|
|
|
CAI
3168
Caris Life Sciences
CAI
$8.39B
| $13.7K | ﹤0.01% |
770
-1,148,363
| -100% | -$20.6M |
2025 Q2
4 quarters
|
|
3169
Civista Bancshares
CIVB
$549M
| $13.6K | ﹤0.01% |
483
| – | – |
2025 Q3
3 quarters
|
|
3170
CS Disco
LAW
$287M
| $13.6K | ﹤0.01% |
3,593
| – | – |
2025 Q4
2 quarters
|
|
3171
Marqeta
MQ
$1.89B
| $13.6K | ﹤0.01% |
835
-175,148
| -100% | -$2.85M |
2021 Q2
20 quarters
|
|
3172
CB Financial Services
CBFV
$189M
| $13.4K | ﹤0.01% |
354
| – | – |
2026 Q1
1 quarter
|
|
3173
908 Devices
MASS
$498M
| $13.4K | ﹤0.01% |
1,536
| – | – |
2025 Q4
2 quarters
|
|
3174
Eton Pharmaceutcials
ETON
$1.58B
| $13.3K | ﹤0.01% |
368
| – | – |
2026 Q1
1 quarter
|
|
3175
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.75B
| $13.3K | ﹤0.01% |
122
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.